HomeAI · summaries
Storia in 8 fonti
US regulators to weigh controversial peptides backed by RFK Jr
FDA has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-ageing.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
fortune.com
The FDA’s peptide vote could create telehealth's next multibillion-dollar market | Fortune
As regulators weigh whether pharmacies can legally compound wellness peptides, companies are preparing for a repeat of the GLP-1 boom—only this time with even murkier science.
- ·
forbes.com
FDA’s Review Of Peptides Signals A Growing Public Health Challenge
A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back their approval for legal compounding.
- ·
FDA Set To Review Safety And Access To Peptides: What You Need To Know
An FDA panel is reviewing seven peptides for potential approval, sparking concerns about their widespread use in compounding pharmacies and the gray market.
- ·
npr.org
Peptides get their regulatory closeup
A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized pharmacies should be allowed to make some popular…
- ·
cbc.ca
U.S. FDA panel to review 7 peptides amid growing popularity | CBC News
U.S. FDA advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if regulators decline to expand access, industry…
- ·
cnn.com
The future of peptides in the US is about to become clearer. Here’s what you should know | CNN
A little-known advisory group to the US Food and Drug Administration will meet this week to mull over whether to ease restrictions on certain peptides. The injectables are popular…
- ·
aljazeera.com
US regulators to weigh controversial peptides backed by RFK Jr
FDA has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-ageing.
- ·
independent.co.uk
FDA reviews peptide injections favored by RFK Jr. and wellness influencers
Federal health advisers are meeting to review a group of controversial chemicals called peptides
- ·
iol.co.za
What's the deal with peptides? The hyped market under US review
The substances under review -- including BPC-157, TB-500 and Semax -- are among those Joe Biden's administration restricted from compounding, notably over lack of human clinical…